2025 Annual Report of Independent Director
As an independent director of North Chemical Industry Co., Ltd. (hereinafter referred to as "the Company"), I have diligently fulfilled my responsibilities in 2025 in accordance with the Company Law, Securities Law, Management Measures for Independent Directors of Listed Companies, Shenzhen Stock Exchange Listing Rules, and relevant regulations. I have actively engaged in understanding the Company's operations and development, attended board and shareholder meetings, participated in major decisions, and provided independent and objective opinions to safeguard the overall interests of the Company and the legitimate rights of all shareholders. Below is my performance report for 2025:
1. Basic Information of the Independent Director
Lv Xianpeng, male, born in January 1964, Chinese nationality, without permanent residency abroad, holds a Ph.D. in Accounting. Currently, I am a professor and doctoral supervisor at Southwestern University of Finance and Economics, an independent director of Sichuan Tianwei Food Group Co., Ltd., an independent director of Luzhou Laojiao Co., Ltd., and an independent director of North Chemical Industry Co., Ltd.
2. Overview of Independent Director's Annual Performance
(1) Meeting Attendance
In 2025, the Company held 9 board meetings and 4 shareholder meetings. My attendance record is as follows:
| Meeting Type | Total Meetings | In-Person Attendance | Attendance by Communication | Proxy Attendance | Absences | Consecutive Absences | Shareholder Meeting Attendance |
|---|---|---|---|---|---|---|---|
| Board Meeting | 9 | 2 | 6 | 1 | 0 | No | 2 |
In 2025, I also served as the convener of the Audit Committee, a member of the Nomination Committee, the Compensation and Assessment Committee, and the Strategy Committee of the fifth board. After the board re-election, I became the convener of the Audit Committee of the sixth board and a member of the Nomination Committee. My attendance at committee meetings and special meetings for independent directors is as follows:
| Meeting Name | Total Meetings | In-Person Attendance | Proxy Attendance | Absences |
|---|---|---|---|---|
| Audit Committee | 6 | 6 | 0 | 0 |
| Nomination Committee | 2 | 2 | 0 | 0 |
| Compensation Committee | 1 | 1 | 0 | 0 |
| Strategy Committee | 3 | 3 | 0 | 0 |
| Special Meeting of Independent Directors | 4 | 4 | 0 | 0 |
For all proposals reviewed at the above meetings, I diligently examined the materials provided by the Company, fully understood the relevant circumstances, and offered opinions and suggestions as an accounting professional. I independently, objectively, and prudently exercised my voting rights, safeguarding the legitimate rights of the Company and all shareholders. I supported all proposals discussed in the meetings held in 2025, with no objections or abstentions.
(2) Exercise of Special Powers as Independent Director
As an independent director, I have diligently fulfilled my responsibilities and exercised my powers in accordance with the law, providing professional opinions at board meetings and special committee meetings.
- There were no instances where independent directors proposed to convene a board meeting.
- There were no proposals from independent directors to hire or dismiss accounting firms.
- There were no independent directors who independently hired external audit or consulting firms.
- There were no proposals from independent directors to convene an extraordinary shareholder meeting.